|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, March 13, 2018 ) The Global leukemia Therapeutics market is projected to reach a market value of 8.82 Billion by 2022 at a CAGR of 9.5% from an estimated market value of 5.6 Billion in 2017.
Leukemia is a subtype of blood cancer which occurs a result of abnormal White Blood Cells production. The primary causes of this disease can be prolonged exposure to radiations, unhealthy lifestyle. These diseases can also be genetically inherited.
Request for a sample: https://www.marketdataforecast.com/market-reports/global-leukemia-therapeutics-market-822/request-sample
The growth in elderly population across the globe and increasing number of people getting affected by leukemia are the two key factors contributing towards the market growth. Also with increasing technological advancements, the access to treatments of leukemia has become more possible.
The key hindering factor of this market is that is the high treatment cost involved. North America has accounted for the major share of the market globally owing to the high awareness towards cancer treatment among people and the funding provided by the government for healthcare. The increasing geriatric population and increasing cancer patients is expected to drive the Asia- Pacific market segment at a high CAGR during the forecast period.
Browse full research report with TOC on "Leukemia Therapeutics Market by disease condition (chronic lymphatic leukemia, acute lymphatic leukemia, chronic myeloid leukemia, acute myeloid leukemia), by diagnosis (CT scan, biopsy, MRI), by treatments (chemotherapy, radiation therapy, immunotherapy, surgery, targeted therapy, bone marrow transplant, stem cell therapy), by drugs (Gleevec, Sapacitabine, GA101, Vasaroxine, Tosedosat), and by Region - Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2017–2022)"
at: https://www.marketdataforecast.com/market-reports/global-leukemia-therapeutics-market-822/
Further Key Findings From the Report Suggest:
• Chronic Myeloid Leukemia segment has accounted for the major market share in comparison to other market segments by disease in 2016.
• Stem cell therapy and bone marrow transplant are expected to witness high growth rates in comparison to other market segments by Diagnosis.
• In the Drugs segment, Gleevec dominated the market in 2016.
• Geographically, North America dominated the global market closely followed by Europe.
About Market Data Forecast
Being a familiar face to the Fortune 500 companies in the field of market research, Market Data Forecast provides its clientele with research material through syndicated reports, consult projects and industry newsletters across various domains and verticals. Our in-house research panel, comprises of industry experts, vertical/domain specialists, supported by a well-built research & data models that help in providing insights for making well-informed decisions. We have a well-established data gathering network across 100+ countries through tie-ups and collaboration’s with the key personnel in value chains & local research organizations. Apart the excellent research services, we also boast of unique post-purchase services offering a 24*7 analyst support for the period of six months. Further, though a continuous feedback from our users, clients and experts, we keep on innovating ourselves in this field to support the organizations in the most efficient ways.
Contact Info:
Name: Mr. Abhishek Shukla
Email: abhishek@marketdataforecast.com
Organization: MarketDataForecast™
Address: 2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
Phone: +1-888-702-9626
Email: abhishek@marketdataforecast.com
Web: https://www.marketdataforecast.com/
Market Data Forecast.
Abhishek Shukla
+1-888-702-9626
abhishek@marketdataforecast.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
